Clinical Research Directory
Browse clinical research sites, groups, and studies.
Microbiological Modulation Of The Oral-Gut Axis After Treatment With Or Without Systemic Use Of Probiotics In Patients With Periodontitis: A Randomized Controlled Clinical Study.
Sponsor: University of Sao Paulo
Summary
This study aims to evaluate whether the oral administration of probiotics, in combination with conventional periodontal treatment (deep cleaning of the tooth root surfaces), can improve oral health and influence the relationship between oral and gut bacteria in individuals with periodontitis. The study will include adults aged 30 years or older diagnosed with advanced periodontitis and receiving treatment at the School of Dentistry of Ribeirão Preto, University of São Paulo (FORP/USP). Individuals with systemic diseases that may interfere with the study outcomes, pregnant or breastfeeding women, smokers, recent former smokers, or individuals who have used antibiotics, probiotics, or certain medications within the previous six months will not be eligible to participate. Participants will be randomly assigned to two groups: one group will receive conventional periodontal treatment alone, while the other will receive the same treatment combined with probiotic supplementation. Before and after treatment, periodontal health will be assessed, including the presence of dental plaque, bleeding, periodontal pocket depth, and clinical attachment levels. Inflammatory substances present in gingival fluid will also be analyzed to evaluate the response to treatment. The findings of this study are expected to help clarify whether probiotics used as an adjunct to periodontal treatment can reduce inflammation and promote a more balanced relationship between oral and gut microorganisms, thereby contributing to improved periodontal health.
Official title: Acronym [*] Required if One Exists. It Will be Included in Parentheses at the End of the Brief Title.
Key Details
Gender
All
Age Range
30 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-06-25
Completion Date
2026-07-15
Last Updated
2026-08-28
Healthy Volunteers
Yes
Conditions
Interventions
Probiotics Bifidobacterium animalis subsp. lactis HN019
The probiotic group will receive a dietary supplement manufactured by Aché Pharmaceuticals containing the strain Bifidobacterium animalis subsp. lactis HN019, while the control group will receive a placebo.
Locations (1)
Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil